-

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080223502

Enrollment

117

Registered

2017-04-05

Start date

2016-03-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

investigational material(s) Generic name etc : - INN of investigational material : Bintrafusp Alfa (Genetical Recombination) Therapeutic category code : 429 Other antitumor agents Dosage and Administr

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

Measure	Time frame
safety -	—

Secondary

Measure	Time frame
efficacy pharmacokinetics -	—

Countries

Asia except Japan, Japan

Outcome results